Translational Aspects in Drug Discovery
Authors:
- L. DetalleLDL. Detalle
- K. VanheusdenKVK. Vanheusden
- M.L. Sargentini-MaierMSM.L. Sargentini-Maier
- T. StöhrTST. Stöhr
- 1 January 2017
- book chapter
- Published by Elsevier
- p. 495-529
Abstract
No abstract availableThis publication has 217 references indexed in Scilit:
- Pharmacokinetic-Pharmacodynamic Modeling of the D2 and 5-HT2A Receptor Occupancy of Risperidone and Paliperidone in RatsPharmaceutical Research, 2012
- Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling of the Dopamine D2 Receptor Occupancy of Olanzapine in RatsPharmaceutical Research, 2011
- Approaches using molecular imaging technology — use of PET in clinical microdose studiesAdvanced Drug Delivery Reviews, 2011
- Application of biomarkers in the development of drugs intended for the treatment of osteoarthritisOsteoarthritis and Cartilage, 2011
- Prediction of Repeat-Dose Occupancy from Single-Dose Data: Characterisation of the Relationship between Plasma Pharmacokinetics and Brain Target OccupancyJournal of Cerebral Blood Flow & Metabolism, 2010
- White paper on imaging biomarkersInsights into Imaging, 2010
- Inflammation and Hemostasis Biomarkers for Predicting Stroke in Postmenopausal Women: The Women's Health Initiative Observational StudyJournal of Stroke and Cerebrovascular Diseases, 2008
- Translational research: Crossing the valley of deathNature, 2008
- Developing translational animal models for symptoms of schizophrenia or bipolar maniaNeurotoxicity Research, 2008
- Application of magnetic resonance imaging in animal models of perinatal hypoxic‐ischemic cerebral injuryInternational Journal of Developmental Neuroscience, 2007